Aurobindo Pharma informs about press release

22 Nov 2023 Evaluate

Aurobindo Pharma has informed that it enclosed a copy of the Press Release titled ‘Evive Biotech and Acrotech Biopharma Announce FDA Approval of Ryzneuta™ (Efbemalenograstim alfa Injection) for ChemotherapyInduced Neutropenia (CIN)’.

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1255.00 14.30 (1.15%)
23-Dec-2024 14:51 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1816.25
Dr. Reddys Lab 1345.00
Cipla 1477.45
Lupin 2163.25
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.